www.instituteofscience.com

ROSENOW'S RECIPES FOR:

M.S.: PREFERABILITY OF AUTOGENOUS VACCINE AND ANTIBODY [57R1]
M.S.: ADMINISTRATION OF VACCINE AND ANTIBODY [57R1]
M.S.: THERAPEUTIC ADMIN. OF VACCINE & ANTIBODY, DOSE [57R1]

57R1: Rosenow, E.C., Studies on the etiology and specific treatment of multiple sclerosis, Ohio M.M., 53(7), July 1957, p. 783-5:

PREFERABILITY OF AUTOGENOUS VACCINE AND ANTIBODY (MS) [57R1]
"Clinical response to the subcutaneous therapeutic injection of heterologous streptococcic vaccine ant thermal antibody solutions, while favorable, was usually not as great nor as constant as it was to the autogenous preparations."

ADMINISTRATION OF VACCINE AND ANTIBODY (M.S.) [57R1]
"One-tenth milliliter of the autogenous or stock vaccine containing 200,000,000 streptococci per milliliter isolated from the nasopharynxes of persons who had multiple sclerosis was injected subcutaneously for the first injection. This dose was increased by 0.1 ml. twice weekly up to the amount of 1 ml. Then 1 ml. was injected each week for an indefinite period, provided local and constitutional reactions were minimal and provided favorable clinical effects occurred. "One-half milliliter of the stock or autogenous [multiple sclerosis] thermal streptococcic antibody from 10 billion streptococci per milliter was injected separately subcutaneously, but at the same time or more often, if favorable results ensued. This dose was increased to 2 ml. and was given twice weekly or daily, provided local reactions at the point of injection were minimal or negative and provided clinical results were favorable."

MS: THERAPEUTIC ADMIN. OF VACCINE & ANTIBODY, DOSE [57R1-783]
"Since such injections were harmless and had to be repeated over long periods, some members of the family or a nurse was instructed to give the injections."

INSTITUTE OF SCIENCE
For more information please visit IoS BOOKS